Status:
NOT_YET_RECRUITING
HIV Self-testing for Partners of HIV-uninfected Postpartum Women
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
HIV Self-testing
Male Partners of HIV-negative Postpartum Women
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test the feasibility and acceptability of a combination intervention to promote HIV self-testing (HIVST) for Partners and PrEP uptake for HIV-uninfected Postpartum Wome...
Eligibility Criteria
Inclusion
- Female
- woman
- Age ≥18
- ≥30 weeks pregnant per medical record due date
- non-reactive third trimester HIV test (verified from their antenatal care chart)
- reporting at least one unknown-serostatus partner
- fluent in English or isiZulu
- willing to give researchers permission to contact them for repeated assessments
- able to provide informed consent
- Male partners meeting the inclusion criteria as described above, and who complete verification questions to confirm their identity and status as the partners of the enrolled female participants. Additional inclusion criteria for men include:
- man
- Age ≥18
- partner of enrolled women, confirmed via couples verification tool
- fluent in English or isiZulu
- willing to give researchers permission to contact them
- able to provide informed consent.
Exclusion
- Individuals with significant psychiatric illness that could interfere with participation or the ability to provide informed consent will be excluded at the discretion of the study team.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 28 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07194902
Start Date
December 1 2025
End Date
August 28 2026
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wits MatCH Research Unit
Durban, KwaZulu-Natal, South Africa